Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D FROHLICH

Showing results (51-60 of 361) with videos related to

Pageof 37
Sort By:
American Heart Journal|March 1, 1991
Vasodilatory beta-blockers: systemic and regional hemodynamic effectsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Hemodynamic differences between black patients and white patients with essential hypertension. State of the art lectureE D Frohlich
Archives of Internal Medicine|June 1, 1977
Essential hypertension. Pathophysiological mechanisms and therapyE D Frohlich
Journal of Cardiovascular Pharmacology|January 1, 1989
Pathophysiology of hypertension: effects of calcium antagonists on heart and kidneyE D Frohlich
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Classification of resistant hypertensionE D Frohlich
Angiology|July 1, 1976
High cardiac output hypertensionsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|June 1, 1987
Multicenter clinical trials. Potential influence of consumer educationE D Frohlich
The American Journal of the Medical Sciences|April 1, 1988
Efferent glomerular arteriolar constriction: a possible intrarenal hemodynamic defect in hypertensionE D Frohlich
Federation Proceedings|June 1, 1982
Hemodynamic factors in the pathogenesis and maintenance of hypertensionE D Frohlich
The American Journal of Cardiology|December 14, 1987
Reversal of target-organ involvement in systemic hypertension: a pharmacologic experienceE D Frohlich
Pageof 37

Showing results (51-60 of 361) with videos related to

Sort By:
Pageof 37
American Heart Journal|March 1, 1991
Vasodilatory beta-blockers: systemic and regional hemodynamic effectsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Hemodynamic differences between black patients and white patients with essential hypertension. State of the art lectureE D Frohlich
Archives of Internal Medicine|June 1, 1977
Essential hypertension. Pathophysiological mechanisms and therapyE D Frohlich
Journal of Cardiovascular Pharmacology|January 1, 1989
Pathophysiology of hypertension: effects of calcium antagonists on heart and kidneyE D Frohlich
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Classification of resistant hypertensionE D Frohlich
Angiology|July 1, 1976
High cardiac output hypertensionsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|June 1, 1987
Multicenter clinical trials. Potential influence of consumer educationE D Frohlich
The American Journal of the Medical Sciences|April 1, 1988
Efferent glomerular arteriolar constriction: a possible intrarenal hemodynamic defect in hypertensionE D Frohlich
Federation Proceedings|June 1, 1982
Hemodynamic factors in the pathogenesis and maintenance of hypertensionE D Frohlich
The American Journal of Cardiology|December 14, 1987
Reversal of target-organ involvement in systemic hypertension: a pharmacologic experienceE D Frohlich
Pageof 37